AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06494384 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Problem Solving Treatment as usual (PST as usual)
Description: PST is a skills-based intervention that teaches clients a 7-step approach in which they 1) select a specific problem and define it in concrete terms,2) select a goal that is feasible to reach before next session, 3) brainstorm various ways to accomplish the goal, 4) evaluate pros and cons of each solution, including the likelihood they can actually implement it, 5) select the best solution, 6) create a plan to implement the solution, and 7) evaluate the plan afterward to ascertain the effectiveness of the solution. Practitioners teach and illustrate the PST process to clients at each session and encourage clients to implement action plans developed using the PST process. Clients are also encouraged to practice the PST process with additional problems between sessions, in order to gain mastery over the PST skills, enhance behavioral activation and as a result improve their belief in their ability to solve problems on their own (self efficacy).
Study NCT06494384 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Problem Solving Treatment Aid (PST-Aid)
Description: PST-Aid is an internet-based tool to support the delivery of PST. PST-Aid incorporates decision support for the practitioner as well as client and provides PST treatment support functions (i.e., scaffolding), including patient problem lists and session worksheets. PST-Aid was designed to be used during remote sessions, such that practitioners and clients can interact throughout the session while collaboratively viewing and editing worksheets on their own browsers.This system was developed into a prototype that was piloted and found to be acceptable and with adequate usability.
Study NCT04891341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Technology Supported Task-Oriented Circuit Training
Description: Ten workstations, which are frequently used in the literature and determined according to the clinical experience of the research team, have been created. Each workstation will be applied for a total of 1 hour, in the form of 5 minutes of training and 1 minute of rest.~1. Sit to stand~2. Standing and trunk training~3. Standing and lower limb training~4. Stepping~5. Walking~6. Walking with object manipulation~7. Climbing and descending stairs~8. Unilateral upper extremity activity training (VR)~9. Bilateral upper extremity activity training (VR)~10. Upper extremity reaction time training (VR) Virtual reality games will be played using the USE-IT intelligent physiotherapy game system. The system offers unilateral, bilateral and bimanual upper extremity training to individuals with a 55 inch touch screen and 7 computer games (balloon popping, car washing, plumbing, arithmetic, apartment, drum and matching).
Study NCT04891341 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home-based Telerehabilitation
Description: Strengthening, balance and coordination exercises will be sent to the participants via a mobile application. Patients will do the exercises at home and send a notification to their physiotherapist. Intervention will be applied for 1 hour, 3 days a week for 8 weeks.
Study NCT05135026 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasonograpgy
Description: 2 USG in 3rd and 5th ANC visits and even more USG if needed + 4 ANC + Health education
Study NCT05755945 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: eHealth Application
Description: Custom phone application that integrates data from smart watch. Subjects will complete daily To-Do-Lists where data will be collected on if they had a headache in the past 24 hours, severity of headache, and any analgesics used to treat the headache.
Study NCT04939519 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Text-Messaging (TM)
Description: Participants in the TM condition will receive HIPAA-compliant bidirectional text messages. These texts will include a brief message alerting patients that they are eligible to receive the vaccine and asking participants if they would like to schedule a vaccine. Participants who reply yes will receive an additional message with information about how and where to register for the vaccine. This information will vary depending on local availability. Participants who reply no will receive a text requesting they contact their local clinic when they decide to receive the vaccine.
Study NCT04939519 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient Navigation (PN)
Description: Participants in the PN condition will receive a message alerting them that a Community Health Worker will contact them to assist with the process of scheduling a vaccine. At this time the participant has the option to opt-out of this follow up phone call. The patient navigation from the Community Health Worker includes practical advice in addressing barriers to vaccination such as logistics and transportation, as well as fear, skepticism, and hesitancy.
Study NCT05506826 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fine motor activities
Description: patient will perform fine motor exercises like therapy ball exercises, therapy putty exercises, table top exercises, moving beans, stacking pennies and rubber band resistances exercises etc. for 30 minutes along with conventional therapy
Study NCT05506826 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional therapy and mirror therapy
Description: Patients in this group will receive conventional therapy for four weeks sixty minutes per day, five days per week. In addition, receive thirty minutes of mirror therapy, which included periodic wrist flexion-extension, flexion and extension exercises of fingers on non paralyzed limb
Study NCT06326892 — intervention group
Intervention type: PROCEDURE
Intervention: Natural Orifice Specimen Extraction (NOSE)
Description: Low rectal cancer resection with Total Mesorectal Excision (TME) and Natural Orifice Specimen Extraction (NOSE)
Study NCT06326892 — intervention group
Intervention type: PROCEDURE
Intervention: Traditional specimen extraction
Description: Low rectal cancer resection with Total Mesorectal Excision (TME) and specimen extraction through Pfannenstiel incision
Study NCT05446428 — intervention group
Intervention type: OTHER
Intervention: study of IFNGS expression biomarkers
Description: Blood tests for serum biomarkers, autoantibodies, cytokine profile etc.
Study NCT05593874 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Histones H3.1 blood levels
Description: Measure of blood concentrations of histone subtype H3.1
Study NCT05731570 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation
Description: Set of restorative and compensatory strategies to rehabilitate cognitive function combined with emotional regulation techniques.
Study NCT04795726 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Finerenone (BAY94-8862)
Description: 10 mg or 20 mg Finerenone tablet to be given orally, once daily, administered in the FIDELIO-DKD or FIGARO-DKD clinical trial.
Study NCT04795726 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo to be taken orally, once daily, administered in the FIDELIO-DKD or FIGARO-DKD clinical trial.
Study NCT06227273 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Hydrogen water
Description: Daily consumption of hydrogen water for 16 weeks.
Study NCT05141162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: case and control group
Description: randomized controlled experimental study
Study NCT05290688 — intervention group
Intervention type: GENETIC
Group type: OTHER
Intervention: 50 ml blodd sampling
Description: 50 ml blood sampling for genetic analysis (expression profiles of microRNAs)
Study NCT04858854 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sulforaphane, administered as Broccoli sprout extract
Description: Patients will randomized to BSE or Control Group. The group BSE will receive the sulforaphane, administered as broccoli sprout extract for 12 weeks. The dose will increase every four weeks if no side-effects are reported (50 µmmol/day; 100 µmmol/day and 150 µmmol/day, respectivelly). The Control group will receive a placebo (maltodextrin sprayed with copper-chlorophyllin) for the same period (12 weeks). The BSE/placebo will be administered as powder provided in 10 ml of water in the morning in a double-blind manner as dry mixtures in sealed portion size bags of similar shape and size.
Study NCT04858854 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sulforaphane, administered as Broccoli sprout extract
Description: Patients will randomized to BSE or Control Group. The group BSE will receive the sulforaphane, administered as broccoli sprout extract for 12 weeks. The dose will increase every four weeks if no side-effects are reported (50 µmmol/day; 100 µmmol/day and 150 µmmol/day, respectivelly). The Control group will receive a placebo (maltodextrin sprayed with copper-chlorophyllin) for the same period (12 weeks). The BSE/placebo will be administered as powder provided in 10 ml of water in the morning in a double-blind manner as dry mixtures in sealed portion size bags of similar shape and size.
Study NCT05644457 — intervention group
Intervention type: GENETIC
Intervention: Circulating tumour DNA dynamics
Description: Circulating tumour DNA (ctDNA) can be identified in patients with a wide variety of cancers and has been shown to allow early prediction of disease relapse after treatment with curative intent in HNSCC.
Study NCT05294354 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: aerobic exercise group (AE)
Description: The participants will ride the cycle ergometer for 35 minutes. The training consisted of a 5-minute warm-up period followed by 25 minutes of moderate exercise and a 5-minute recovery.
Study NCT05294354 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: aerobic exercise with virtual reality group (AE-VR)
Description: The participants will receive the 3D VR training program and ride the cycle ergometer at the same time. The training protocol is similar to the aerobic exercise group.
Study NCT05294354 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: combined exercise group (CE)
Description: The intervention consists of 5-minutes aerobic warm-up, 25-minutes bodyweight exercise, and 5-minutes mindfulness meditation for recovery. The participants will follow the video to do the program.
Study NCT05294354 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Participants will watch a 35-min video about exercise science.
Study NCT06200649 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: massage
Description: Massage application; It will be done on the back, which is the five basic massage areas. Massage application will be started with eflorage. The massage will be continued with petrissage by grasping the subcutaneous tissue and muscle layer with the help of thumb and other fingers, starting from the waist circumference. Petrissage will be applied for 5 minutes. After petrissage, the massage was continued with friction movements, which is the other stage. Friction will be applied for 5 minutes. Tapotment will be done after friction. Tapotman will take 5 minutes. After taping, the entire back area will be finished by efflorescence for 2 minutes, just like at the beginning.
Study NCT05232006 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niraparib
Description: Niraparib, once daily
Study NCT05697263 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Periodization of training
Description: Participants in the three arms will exercise the same dose and number of sessions distributed in three different ways.
Study NCT04967222 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Reappraisal by Distancing
Description: Reappraisal-by-distancing treatment. Participants meet 2 times a week for 6 weeks to learn reappraisal by distancing through repeated practice with negative emotional pictures. The therapist will help model and shape the technique. .
Study NCT04967222 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Downregulate Condition
Description: Participants either meet 2x a week for 6- weeks to gain added practice, under the guidance of a therapist, using their customary emotion regulatory strategies to downregulate their negative reactions to aversive pictures.
Study NCT05440396 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Photographs collection phase
Description: Three medical experts have been selected to review the photo collected. Each expert medical assesses the presence of local signs of infection on the photographs by annotating them directly via a dedicated software. They will annotate local signs: redness, perfusion extravasation, necrosis, hematoma, edema, non-purulent discharge, and purulent discharge.~A convolutional neural network model will determine the probability of local sign presence. Each picture will be annotated to determine the main characteristics of the catheter. A dataset preparation with photo cropping will be performed for modelling.
Study NCT03311451 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: C2 CryoBalloon 180° Ablation System
Description: The C2 CryoBalloon 180° Ablation System is a cryosurgical device with a nitrous oxide cooled balloon probe that is compatible with upper gastrointestinal therapeutic endoscopes.
Study NCT05902078 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eldecalcitol capsules
Description: Oral eldecalcitol 0.75μg daily
Study NCT05902078 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcitriol capsules
Description: Oral calcitriol 0.5μg daily
Study NCT05662696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Raabta Telemonitoring Program (Mobile Application)
Description: Raabta is a smartphone application that will allow pregnant women at high-risk for preeclampsia to measure and record daily blood pressure readings and self-reported symptoms. An algorithm is used to generate an alert to a healthcare provider as necessary. The patient also receives an automated alert self-care message based on their measurements and reported symptoms.
Study NCT05010954 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LXI-15028 50mg group
Description: The investigational products are administrated orally, once in the morning every day, and each dose includes 2 tablets of investigational products (LXI-15028 50mg active agent + Lansoprazole 30mg matching placebo). If the investigational product is not taken in the morning, subjects can take it before 6:00 p.m. on the same day. The duration of treatment is 4 or 6 weeks
Study NCT05010954 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lansoprazole 30mg group
Description: The investigational products are administrated orally, once in the morning every day, and each dose includes 2 tablets of investigational products ( LXI-15028 50mg matching placebo + Lansoprazole 30mg active agent ). If the investigational product is not taken in the morning, subjects can take it before 6:00 p.m. on the same day. The duration of treatment is 4 or 6 weeks.
Study NCT06131333 — intervention group
Intervention type: PROCEDURE
Intervention: Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation
Description: PCI was performed according to the general and local recommendations. The choice of DES among the new generation DES and the decision on procedure optimization belonged to the operator.
Study NCT06515600 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Practice flow trigger sensitivity adjustment on mechanical ventilation for 1 week twice daily in addition to their plan of treatment.
Description: All patients were investigated by routine investigation (vital signs, arterial blood gas, ventilator mode, and the parameters).~Two sessions were implemented per day for the study group for one week. The Trigger sensitivity adjustment trial begins with applying a load of 30% of the first recorded Negative Inspiratory Force (NIF).~1. st Day 1st session, 30% 5 min.~2. nd session, 30% 10 min.~2nd Day 1st session, 30% 15 min 2nd session, 30% 20 min.~3rd Day 1st session, 30% 25 min. 2nd session, 30% 30 min.~4th Day 1st session, 40% 5 min. 2nd session, 40% 10 min.~5th Day 1st session 40% 15 min 2nd session 40% 20 min.~6th Day 1st session 40% 25 min. 2nd session 40% 30 min.~7th Day 1st session 50% 5 min. 2nd session 50% 10 min.
Study NCT06515600 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Practice flow trigger sensitivity adjustment on mechanical ventilation for 1 week twice daily in addition to their plan of treatment.
Description: All patients were investigated by routine investigation (vital signs, arterial blood gas, ventilator mode, and the parameters).~Two sessions were implemented per day for the study group for one week. The Trigger sensitivity adjustment trial begins with applying a load of 30% of the first recorded Negative Inspiratory Force (NIF).~1. st Day 1st session, 30% 5 min.~2. nd session, 30% 10 min.~2nd Day 1st session, 30% 15 min 2nd session, 30% 20 min.~3rd Day 1st session, 30% 25 min. 2nd session, 30% 30 min.~4th Day 1st session, 40% 5 min. 2nd session, 40% 10 min.~5th Day 1st session 40% 15 min 2nd session 40% 20 min.~6th Day 1st session 40% 25 min. 2nd session 40% 30 min.~7th Day 1st session 50% 5 min. 2nd session 50% 10 min.
Study NCT02177721 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Collection of samples
Description: Whenever possible serum samples will be collected from all subjects to determine serum raxibacumab concentrations pre-infusion, and at specific timepoints post-infusion. In the event cerebrospinal fluid (CSF), pleural, ascites, or bronchoalveolar lavage (BAL) fluid are collected for ad hoc clinical laboratory testing, any remaining excess sample will be provided to Sponsor for determination of raxibacumab concentrations.~Any available serum remaining from ad hoc clinical laboratory specimen collections prior to raxibacumab administration will be provided to Sponsor for measurement of serum PA concentrations. In addition, remaining post raxibacumab dose serum specimens may also be analyzed for TNA or ADA.
Study NCT05151120 — intervention group
Intervention type: BIOLOGICAL
Intervention: blood sample
Description: In practice the only intervention of the study is 49 mL extra blood along with the blood draw that is already planned for diagnosis/follow-up
Study NCT04616248 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-CD40 Agonist Monoclonal Antibody CDX-1140
Description: Given IT
Study NCT04616248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Poly ICLC
Description: Given IT
Study NCT04616248 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiation therapy
Study NCT04616248 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Flt3 Ligand
Description: Given IT
Study NCT04616248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT04616248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Description: Given SC
Study NCT05744570 — intervention group
Intervention type: PROCEDURE
Intervention: Epidural anesthesia
Description: Regional anesthesia for labor pain
Study NCT04993833 — intervention group
Intervention type: DEVICE
Intervention: NPi-200 and NPi-300 pupillometers
Description: Device which measures PLR.
Study NCT06034535 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD62L depleted donor lymphocyte infusion
Description: Intravenous infusion of CD62L depleted donor lymphocytes
Study NCT05245019 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: cardamom
Description: cardamom is used as a flavoring agent in foods as well as for treating various cardiovascular, gastrointestinal, and neural problems
Study NCT05245019 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: fennel
Description: fennel is Known for its anti-inflammatory, anti-spasmodic, and analgesic properties, it is also widely used for treating gastroenteritis and indigestion.
Study NCT06427291 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Herpes virus T3011 injection
Description: T3011 will be instilled in the entire solution volume of 50ml, and be will be left in the bladder for at least 1 hour, no more than 2 hours. After competing instillation, the patients should be instructed to drink at lest 1000mL of water
Study NCT05619302 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [68Ga]CBP8 PET/MRI
Description: Simultaneous cardiac PET/MRI images will be obtained following injection of \[68Ga\]CBP8
Study NCT05619302 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: [68Ga]CBP8 PET/MRI
Description: Simultaneous cardiac PET/MRI images will be obtained following injection of \[68Ga\]CBP8
Study NCT05619302 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: [68Ga]CBP8 PET/MRI
Description: Simultaneous cardiac PET/MRI images will be obtained following injection of \[68Ga\]CBP8
Study NCT04255147 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells
Description: Cryopreserved allogeneic umbilical cord tissue-derived mesenchymal stromal cells are thawed and administered intravenously.
Study NCT04682704 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Parasym
Description: Tragus stimulation
Study NCT04682704 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Parasym
Description: Tragus stimulation
Study NCT06308432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low intensity
Description: The subject will perform the 30-minute test at an intensity of 50% of the power at which he/she has reached his/her VO2max.
Study NCT06308432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low temperature
Description: The performance test will be carried out in a room conditioned to a temperature of 22º.
Study NCT06308432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Humidity
Description: The performance test will be carried out in a room conditioned to 40% humidity.
Study NCT06308432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity
Description: The subject will perform the 30-minute test at an intensity of 60% of the power at which he/she has reached his/her VO2max.